The latest price target for Gentex (NASDAQ:GNTX) was reported by UBS on February 3, 2025. The analyst firm set a price target for $29.00 expecting GNTX to rise to within 12 months (a possible 19.79% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Gentex (NASDAQ:GNTX) was provided by UBS, and Gentex maintained their neutral rating.

The last upgrade for Gentex Corp happened on July 6, 2023 when B of A Securities raised their price target to $33. B of A Securities previously had an underperform for Gentex Corp.

There is no last downgrade for Gentex.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gentex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gentex was filed on February 3, 2025 so you should expect the next rating to be made available sometime around February 3, 2026.

While ratings are subjective and will change, the latest Gentex (GNTX) rating was a maintained with a price target of $30.00 to $29.00. The current price Gentex (GNTX) is trading at is $24.21, which is out of the analyst’s predicted range.